Accelerated approval pathways can help bring treatments to patients sooner—but accelerated timelines require trustworthy evidence, standardized data and technology built for faster regulatory readiness.

From surrogate and intermediate endpoints to data transparency and submission standards, the IDDI and Marvin EDC experts examine what it takes to build trustworthy evidence on accelerated timelines and discover why planning for regulatory submission from the start can help teams move from promising early signals to reliable evidence—and ultimately bring treatments to patients sooner.

Speakers:

  • Leandro Garcia Barrado, Principal Statistical Scientist, IDDI
  • Nicole Kuisle, Head of Customer Success, Marvin EDC by AB Cube

Key Learnings:

  • Understand accelerated approval pathway: Using earlier endpoints to support earlier access to promising treatments
  • Explore strategies for confirmatory evidence: From separate trials to adaptive seamless designs
  • See why data transparency and standardization matter: Building trustworthy evidence for regulatory decisions
  • Plan for submission readiness from the start: Aligning EDC design, data standards and workflows early
  • Use EDC as a strategic enabler: Supporting real-time data visibility, transformation and accelerated timelines

Watch episode 1: From Protocol to Platform: Flexible Randomization and Seamless Design in Practice

Watch episode 2: Turning Data Into Decisions: Real-Time Reporting Meets Group-Sequential Designs

About the podcast series:

When Methodology Meets Technology explores how intelligent trial design and digital agility can work together to address the growing complexity of clinical research. Across three episodes, experts from IDDI and Marvin EDC discuss how statistical innovation, connected data and flexible technology can help translate advanced trial designs into clinical practice.

Back to Resources

When every data point represents a patient, accuracy and integrity aren’t optional — they’re everything. That’s why it’s IDDI.

Start Now